UBS announced on Thursday that it has received initial conditional approval from U.S. regulators for a national bank charter for its American franchise, a critical step in its multi-year effort to expand its domestic banking operations. The conditional approval, granted by the Office of the Comptroller of the Currency, follows a comprehensive review of UBS’s capital adequacy, risk-management framework and governance structures. UBS’s U.S. unit manages approximately $500 billion in client assets and reported net new asset inflows of $12 billion in the third quarter of 2025, underlining the strategic importance of securing full charter status to accelerate credit origination and deposit gathering in North America.

In a research note published this week, UBS analysts advised investors to reduce exposure to GE HealthCare shares, warning that competitive pressures from both Chinese medical-imaging manufacturers and impending generic alternatives could erode the company’s market share. The UBS team highlighted that GE HealthCare’s U.S. imaging equipment revenues grew just 3% year-over-year in the first nine months of 2025 and that Chinese suppliers have captured 15% of the global ultrasound market by offering models at price points up to 30% lower. UBS argued that until the competitive landscape becomes clearer, potential revenue downgrades of 5% to 10% in 2026 could significantly impact GE HealthCare’s valuation.

UBS’s commodities research group forecasts further gains in gold prices after bullion climbed roughly 7% so far in 2026, on top of a near 65% rally throughout 2025. In its latest outlook, UBS economists cited persistent global inflationary pressures, and geopolitical tensions in Eastern Europe and the Middle East as drivers likely to sustain safe-haven demand. The bank projects average annualized gold returns of 10% through year-end 2027 and recommends that institutional portfolios maintain a 5% to 8% weighting in bullion to hedge against currency volatility and potential central bank diversification away from the U.S. dollar.

In a recent interview with Swiss newspaper Tages-Anzeiger, UBS Chief Executive Officer Sergio Ermotti reiterated his preference for selecting his successor from within the firm’s existing management ranks. Ermotti noted that UBS’s bench strength has been bolstered by six senior promotions over the past 18 months, including new heads of wealth management and investment banking, each responsible for over $200 billion in client assets. He underscored the importance of institutional knowledge and cultural continuity, suggesting that an internal candidate could more seamlessly advance the bank’s strategic priorities, including digital transformation and cross-border integration initiatives.